Deal Terms Reviews — Discover what people think of this product.

Deal Terms

Know your deal's worth before the room does.

Startup buildersWeb Tool/AppSubscription

Life Sciences Deal Calculator gives biotech founders, BD executives, and investors instant deal term benchmarks from 600+ real transactions, sourced directly from SEC EDGAR filings, Clinical Trials, and press releases. Enter your asset's phase, modality, and indication. Get upfront payment ranges, milestone structures, royalty rates, and AI-powered partner matches in under 3 seconds. Free to start. No spreadsheets, no $25,000 consulting reports, just defensible benchmarks when it matters most.

What users think of Deal Terms

Maker

Issa

Supporters

Idea

4.3

Product

5.0

Feedback

Roasted

Back to Rankings

More about Deal Terms

Biotech founders negotiate billion-dollar licensing deals against seasoned Big Pharma BD teams, usually without seeing a single comparable transaction. That information gap costs companies real money.

Life Sciences Deal Calculator closes it. Powered by 600+ publicly disclosed deals across oncology, neurology, immunology, and metabolic/obesity, the platform delivers instant, data-driven benchmarks for upfront payments, development milestones, regulatory milestones, and royalty rates, calibrated to your specific asset: phase, modality, and indication.

Our AI partner-matching engine screens 50+ pharma companies against your asset profile and surfaces the best-fit licensing partners by therapeutic focus, deal history, and patent cliff activity. What used to take weeks and cost $5,000–$25,000 per analysis now takes 30 seconds and is free to start.

Built by Ambrosia Ventures, a boutique life sciences strategy and M&A advisory firm, the calculator reflects real transaction intelligence we use in our own advisory engagements. Pro subscribers get full milestone breakdowns, partner profiles, PDF and Excel exports, and unlimited analyses, the tools serious BD professionals need to walk into any room with confidence.